225 related articles for article (PubMed ID: 6851057)
21. Usefulness of electrophysiologic testing in evaluation of amiodarone therapy for sustained ventricular tachyarrhythmias associated with coronary heart disease.
Horowitz LN; Greenspan AM; Spielman SR; Webb CR; Morganroth J; Rotmensch H; Sokoloff NM; Rae AP; Segal BL; Kay HR
Am J Cardiol; 1985 Feb; 55(4):367-71. PubMed ID: 3969870
[TBL] [Abstract][Full Text] [Related]
22. Antiarrhythmic actions of amiodarone: a profile of a paradoxical agent.
Singh BN
Am J Cardiol; 1996 Aug; 78(4A):41-53. PubMed ID: 8780328
[TBL] [Abstract][Full Text] [Related]
23. Antiarrhythmic efficacy and electrophysiologic actions of amiodarone in patients with life-threatening ventricular arrhythmias: potent suppression of spontaneously occurring tachyarrhythmias versus inconsistent abolition of induced ventricular tachycardia.
Nademanee K; Hendrickson J; Kannan R; Singh BN
Am Heart J; 1982 Jun; 103(6):950-9. PubMed ID: 7081035
[No Abstract] [Full Text] [Related]
24. Effects of a new amiodarone-like agent, SR 33589, in comparison to amiodarone, D,L-sotalol, and lignocaine, on ischemia-induced ventricular arrhythmias in anesthetized pigs.
Finance O; Manning A; Chatelain P
J Cardiovasc Pharmacol; 1995 Oct; 26(4):570-6. PubMed ID: 8569217
[TBL] [Abstract][Full Text] [Related]
25. Long-term low-dose amiodarone therapy in the management of ventricular and supraventricular tachyarrhythmias: efficacy and safety.
Lee KL; Tai YT
Clin Cardiol; 1997 Apr; 20(4):372-7. PubMed ID: 9098598
[TBL] [Abstract][Full Text] [Related]
26. Low dose amiodarone in refractory tachyarrhythmias.
Panja M; Maity AK; Kar AK; Chatterjee SS; Kumar S; Roy S; Sinha DP; Majumdar B; Panja S
Indian Heart J; 1992; 44(1):47-9. PubMed ID: 1398696
[TBL] [Abstract][Full Text] [Related]
27. Amiodarone treatment in patients with ventricular arrhythmias.
Prystowsky EN; Heger JJ; Miles WM; Zipes DP
Drugs; 1985 Mar; 29 Suppl 3():47-52. PubMed ID: 3996245
[TBL] [Abstract][Full Text] [Related]
28. Steady-state serum amiodarone concentrations: relationships with antiarrhythmic efficacy and toxicity.
Rotmensch HH; Belhassen B; Swanson BN; Shoshani D; Spielman SR; Greenspon AJ; Greenspan AM; Vlasses PH; Horowitz LN
Ann Intern Med; 1984 Oct; 101(4):462-9. PubMed ID: 6476633
[TBL] [Abstract][Full Text] [Related]
29. Amiodarone: an effective alternative for recalcitrant supraventricular and ventricular tachycardias.
Best JF; Rinkenberger R; Lynch L; Dunn M
Clin Cardiol; 1986 Jun; 9(6):268-71. PubMed ID: 2424656
[TBL] [Abstract][Full Text] [Related]
30. Efficacy and safety of amiodarone in treatment of refractory atrial and ventricular tachyarrhythmias.
Kato K
Ann N Y Acad Sci; 1992 Jan; 644():235-45. PubMed ID: 1562118
[TBL] [Abstract][Full Text] [Related]
31. Value of Holter monitoring in identifying risk for sustained ventricular arrhythmia recurrence on amiodarone.
Marchlinski FE; Buxton AE; Flores BT; Doherty JU; Waxman HL; Josephson ME
Am J Cardiol; 1985 Mar; 55(6):709-12. PubMed ID: 3976513
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of amiodarone therapy in the treatment of drug-resistant cardiac arrhythmias: long-term follow-up.
Peter T; Hamer A; Mandel WJ; Weiss D
Am Heart J; 1983 Oct; 106(4 Pt 2):943-50. PubMed ID: 6613841
[TBL] [Abstract][Full Text] [Related]
33. Clinical pharmacology of amiodarone.
Marcus FI
Ann N Y Acad Sci; 1984; 427():112-26. PubMed ID: 6378011
[No Abstract] [Full Text] [Related]
34. Management of refractory sustained ventricular tachycardia with amiodarone: a reappraisal.
Lavery D; Saksena S
Am Heart J; 1987 Jan; 113(1):49-56. PubMed ID: 3799441
[TBL] [Abstract][Full Text] [Related]
35. Amiodarone in the treatment of patients with refractory symptomatic ventricular and supraventricular arrhythmias. A long-term follow-up study.
Lloyd EA; Mabin TA
S Afr Med J; 1983 May; 63(20):759-63. PubMed ID: 6342169
[TBL] [Abstract][Full Text] [Related]
36. [Antiarrhythmic effect and side effects of amiodarone].
Weber H; Weissel M; Haddad R; Scheibelhofer W; Konrad K; Mlczoch J; Probst P; Mainitz M
Wien Klin Wochenschr; 1984 Sep; 96(18):685-96. PubMed ID: 6523885
[TBL] [Abstract][Full Text] [Related]
37. Ten years of experience with amiodarone.
Rosenbaum MB; Chiale PA; Haedo A; Lázzari JO; Elizari MV
Am Heart J; 1983 Oct; 106(4 Pt 2):957-64. PubMed ID: 6613843
[TBL] [Abstract][Full Text] [Related]
38. Long-term tolerance of amiodarone treatment for cardiac arrhythmias.
Smith WM; Lubbe WF; Whitlock RM; Mercer J; Rutherford JD; Roche AH
Am J Cardiol; 1986 Jun; 57(15):1288-93. PubMed ID: 3717027
[TBL] [Abstract][Full Text] [Related]
39. Amiodarone and sustained ventricular arrhythmias: statistical evidence of drug effectiveness.
Flaker GC; Alpert MA; Webel RR; Ruder MA; Sanfelippo JF; Tsutakawa RK
Am Heart J; 1985 Aug; 110(2):371-6. PubMed ID: 4025112
[TBL] [Abstract][Full Text] [Related]
40. Amiodarone for control of sustained ventricular tachyarrhythmia: clinical and electrophysiologic effects in 51 patients.
Waxman HL; Groh WC; Marchlinski FE; Buxton AE; Sadowski LM; Horowitz LN; Josephson ME; Kastor JA
Am J Cardiol; 1982 Nov; 50(5):1066-74. PubMed ID: 6291368
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
